Skip to content

Rafael Holdings, Inc. RFL Acquired in-process research and development and milestones

Acquired in-process research and development and milestones at other companies

RFL
Rafael Holdings, Inc.RFL
$4M0.0%
RFL
Rafael Holdings, Inc.RFL
$4M0.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$0
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$296K0.0%
Biogen logo
BiogenBIIB
$117.95M+667%
OS Therapies logo
OS TherapiesOSTX
$7.35M+462%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired.

The official record: Rafael Holdings, Inc.’s 10-Q, filed December 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s acquired in-process research and development and milestones.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s acquired in-process research and development and milestones?
Rafael Holdings, Inc. (RFL) reported acquired in-process research and development and milestones of $4M in Q3 2025.
How has Rafael Holdings, Inc.'s acquired in-process research and development and milestones changed year-over-year?
Rafael Holdings, Inc.'s acquired in-process research and development and milestones decreased by 0.0% year-over-year, from $4M to $4M.
What does acquired in-process research and development and milestones mean?
The fair value of research and development assets acquired through means other than a traditional business combination, such as direct asset purchases or licensing agreements. This metric tracks the company's investment in its intellectual property pipeline.